Association between serum ferritin level and lipid profile among diabetic patients: A retrospective cohort study

Author:

Alqahtani Saif Aboud M1,Alsaleem Mohammed Abadi2,Ghazy Ramy Mohamed23ORCID

Affiliation:

1. Internal Medicine Department, College of Medicine, King Khalid University, Abha, Saudia Arabia

2. Department of Family and Community Medicine, College of Medicine, King Khalid University, Abha, Saudia Arabia

3. Tropical Health Department, High Institute of Public Health, Alexandria University, Alexandria, Egypt.

Abstract

High serum ferritin (SF) levels have been linked to obesity, metabolic syndrome, atherosclerosis, diabetes, dyslipidemia, and cancer. This study aimed to investigate the association between SF and dyslipidemia in adults diagnosed with diabetes mellitus. This cross-sectional study retrospectively analyzed the electronic medical records of eligible patients from 3 primary locations in Saudi Arabia namely – Abha, Khamis Mushyt, and Jeddah – from 2010 to 2020. The study included adult patients aged 18 years or older who were diagnosed with diabetes mellitus and identified with an HbA1c level of ≥6.5. This study involved 3674 participants, with males accounting for 26.6% of the total. The mean age of the studied population was 48.0 ± 18.4 years. The median [interquartile range] of SF among males was higher than females, however, this difference was not statistically significant (60.0 [23.4–125.8] vs 55.4 [24.0–113.4], P = 0.204). On the other hand, age and region were significantly associated with SF (P = .032 and 0.035). SF had a significant positive correlation with cholesterol (r = 0.081, P < .001), low-density lipoprotein cholesterol (r = .087, P < .001), and triglycerides (r = 0.068, P < .001) and negative correlation with high-density lipoprotein cholesterol (r = −0.13, P < .001). Multivariate analysis revealed that age, sex, residence, and HbA1c were significantly affecting the lipid profile. Clinicians should consider including SF testing as part of the comprehensive evaluation of patients with diabetes and dyslipidemia.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Reference37 articles.

1. Atherogenic Index of Plasma (AIP): a marker of cardiovascular disease.;Niroumand;Med J Islam Repub Iran,2015

2. Heart disease and stroke statistics–2011 update: a report from the American Heart Association.;Roger;Circulation,2011

3. LDL/apo B ratio predict coronary heart disease in type 2 diabetes independent of ASCVD risk score: a case-cohort study.;Rabizadeh;Nutr Metab Cardiovasc Dis,2021

4. Adipose tissue dysfunction contributes to obesity related metabolic diseases.;Blüher;Best Pract Res Clin Endocrinol Metab,2013

5. Dyslipidemia in pediatric type 2 diabetes mellitus.;Sunil;Curr Diab Rep,2020

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3